A. M. Richards

发表

Association between endothelin type A receptor haplotypes and mortality in coronary heart disease.

T. Yandle, R. Troughton, A. Pilbrow, 2012, Personalized Medicine.

Analytical, biochemical and clearance considerations of soluble urokinase plasminogen activator receptor (suPAR) in healthy individuals.

A. Richards, R. Troughton, C. Pemberton, 2019, Clinical biochemistry.

2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial.

C. Reid, J. Greenslade, J. Kline, 2012, Journal of the American College of Cardiology.

A 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department: a randomized clinical trial.

Joanna M. Young, S. Goodacre, M. Ardagh, 2014, JAMA internal medicine.

Resistin worsens cardiac ischaemia-reperfusion injury.

A. Richards, C. Pemberton, S. E. Rothwell, 2006, Biochemical and biophysical research communications.

Diagnostic and prognostic performance of the ratio between high-sensitivity cardiac troponin I and troponin T in patients with chest pain

J. Greenslade, J. Pickering, B. Lindahl, 2022, PloS one.

Natriuretic peptides in heart failure with preserved ejection fraction.

J. Januzzi, A. Richards, R. Troughton, 2014, Heart failure clinics.

High-sensitivity troponin T for early rule-out of myocardial infarction in recent onset chest pain

R. Troughton, M. Than, C. Pemberton, 2011, Emergency Medicine Journal.

ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical Pathway

A. Jaffe, J. Pickering, A. Kerr, 2017, Circulation.

Determination of Clinically Acceptable Analytical Variation of Cardiac Troponin at Decision Thresholds.

P. Kavsak, Laura R Joyce, A. M. Richards, 2024, Clinical chemistry.